Submissions from 2022
Trauma/Reconstruction/Diversion: External Genitalia Reconstruction and Urotrauma (including Transgender Surgery), Frank Burks
Ureteral Repair, Frank Burks
Debate: First Line Medical Therapy for a 60 Year Old Female with OAB-Beta Agonists Versus Anticholinergics, Michael Chancellor
COVID Associated Cystitis (CAC), Michael B. Chancellor
Testosterone Treatment for Hypogonadism and Aging-Related Prostate Gland Diseases: Evidence-Based New Approach, Ananias Diokno
Make a Wish: Happy Birthday Bladder Candle, Alexander Geisenhoff, Mit Shah, and Megan Schober
Trigger Point Injections for Pelvic Pain, Jason Gilleran
When Neuromodulation Stops Working – A Case-Based Approach to Troubleshooting the Patient, the Practitioner and the Device, Jason P. Gilleran, Kathleen C. Kobashi, Colin M. Goudelocke, and Aqsa A. Khan
Advanced Prostate Cancer Treatments: The Large Urology Group Practice Model, Jason Hafron
Comparison of Major Adverse Cardiovascular Events Risk with Androgen Deprivation Therapy by Personal History of Cardiovascular Diseases using Real World Data, Jason Hafron, Deborah Boldt-Houle, and Stuart Atkinson
A 66-Year-Old-Man with Metastatic Prostate Cancer, Jason M. Hafron
Dr. Hafron explains the benefits of Jelmyto in UTUC since its approval, Jason M. Hafron
Dr. Hafron highlights the most significant prostate cancer treatment advances in 2022, Jason M. Hafron
Balloon Debate: Management of Asymptomatic 1 cm Lower Pole Stone: Shockwave Lithotripsy, William K. Johnston III
Freeing Up Your Hands during Endourology, William K. Johnston III
Innovation, Development, Experiments, Assessment (IDEA) Research Forum: CystoAssist's Role in Reducing Ureteral Trauma and Increasing Stentless Ureteroscopy., William K. Johnston III
Pain Relief After Ureterocopy: Listen to the MUSIC, William K. Johnston III
ISOPSA: Clinical Performance of a Single Parameter, Structure Based Test for High Grade Prostate Cancer Unaffected by 5-ARI and A-Blocker Medications, Eric Klein, Alan Partin, Yair Lotan, Jack Baniel, Martin Dineen, Jason Hafron, Kannan Manickam, Marc Pliskin, Matthew Wagnet, and AO Zhang
Successful Treatment of Symptomatic Cystitis Glandularis Presenting as Bladder Mass, with COX-2 Inhibitor: A Case Report, Bilal Muhammad and Kenneth Peters
COVID Associated Cystitis (CAC): Neuromodulation for Neurogenic Bladder, Priya Padmanabhan
Evaluation & Management of Female Incontinence, Priya Padmanabhan
Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-Neurogenic Voiding Dysfunction II, Priya Padmanabhan
Urological Complications of Gynecological Surgery, Priya Padmanabhan
Beaumont Urology Research - Improving Patient Care Through Innovation, Kenneth Peters
Pudendal Neuromodulation: Diagnosis and Management of Pelvic Pain, Kenneth Peters
Standardizing the Pelvic Floor Exam: Is It Reproducible and Durable?, Ly Hoang Roberts, Bernadette Zwaans, Daniel T. Fortney, Steven A. Kessler, Hailey Eisner, Lauren E. Tennyson, Kenneth M. Peters, and Larry T. Sirls
The Incidence of New or Worsening OAB Symptoms in Patients with Prior SARS COV-2 Infection, Ly Hoang Roberts, Bernadette Zwaans, and Priya Padmanabhan
Treatment of unfavorable intermediate risk prostate cancer, Ashley Ross, Jason Hafron, and Katie Murray
Urinary cytokines as potential biomarkers of mild cognitive impairment and Alzheimer’s disease: a pilot study, Nazia Saiyed Saiyed, Ali Yilmaz, Sangeetha Vishweswariah, Sarah Bartolone, Tammy Osentoski, Stacey Ruff, Amita Pai, Michael Maddens, Khaled Imam, and Stewart F. Graham
Anatomic Study of Pelvic Floor Injections, Larry Sirls
Combined Clinical Risk score-based thresholds across National Comprehensive Cancer Network (NCCN) intermediate risk patients with prostate cancer, Jonathan D. Tward, Lauren Lenz, Adam Cole, Jason Hafron, Edward Uchio, Robert Finch, Sarah Tatzel, Thomas Slavin, and Todd Cohen
Safety, Tolerability, and Efficacy of TAR-200 in Patients with Muscle-Invasive Bladder Cancer Who Refused or Were Unfit for Curative-Intent Therapy: A Phase 1 study, Mark D. Tyson, David Morris, Juan Palou, Marie Carmen Mir, Rian J. Dickstein, Felix Guerrero-Ramos, and Jason M. Hafron
Implantable Neuromodulation in the Setting of Neurgenic Bladder: Single-Institution Experience, Annah Vollstedt, Brett Friedman, Ly Hoang Roberts, Hailey Eisner, Jason P. Gilleran, Kenneth M Peters, and Priya Padmanabhan
Cancer Survivorship in Older Urologic Patients: Issues After Pelvic Radiation, Bernadette Zwaans
The Effect of Radiation on Aging Hallmarks, Inflammation and Fibrosis, in Bladder Function, Bernadette Zwaans
Submissions from 2021
Dr. Chancellor discusses novel regenerative therapy for recurrent SUI, Michael B. Chancellor
Around the Practice: Improving Outcomes in Advanced Prostate Cancer, Raoul S. Concepcion, Jason M. Hafron, Daniel P. Petrylak, Oliver Sartor, and Leonard G. Gomella
Urgency, Frequency and Pelvic Pain: Looking Beyond the Bladder, Jason Gilleran and Laura Krasean
Developing a Point-of-Risk Test for Novel Coronavirus 2019, Laura E. Lamb